myostatin peptibodies (Amgen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namemyostatin peptibodies (Amgen)

Drug Alias Namemyostatin-based therapy (Amgen)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody fragmentBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionGrowth/differentiation factor 8 inhibitors

TargetsGrowth/differentiation factor 8

Therapy Area/IndicationsMuscular Atrophy

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAmgen Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAmgen Inc

Active IndicationsN/A

Inactive IndicationsMuscular Atrophy

Other Information

ATC CodeN/A